<DOC>
	<DOCNO>NCT01223053</DOCNO>
	<brief_summary>Transdel Pharmaceuticals investigate topical cream formulation consist 10 % ketoprofen local treatment pain associate mild moderate acute soft tissue injury confirmatory Phase 3 trial .</brief_summary>
	<brief_title>Ketoprofen 10 % Cream Treatment Pain Associated With Mild Moderate Acute Soft Tissue Injury</brief_title>
	<detailed_description>This Phase 3 study examines use TDLP-110 ( a.k.a . KetotransdelÂ® ketoprofen 10 % cream ) , topical treatment pain associate mild moderate acute soft tissue injury upper low extremity serve confirmatory trial . The first complete Phase 3 study show efficacy safety TDLP-110 compare placebo improve patient assessment pain .</detailed_description>
	<mesh_term>Soft Tissue Injuries</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Are male female 18 75 year age , inclusive . Female patient childbearing potential must practice abstinence use medically acceptable form contraception Have diagnosis uncomplicated acute soft tissue injury upper low extremity , include acute injury ligament , tendon , muscle ( include Grade 1 Grade 2 sprain strain ) , occur within 60 hour precede baseline visit . Meet pain intensity criterion Are willing discontinue use pain medication treatment provide part study . Participation previous clinical study drug TDLP110 ( ketoprofen 10 % cream ) . Are pregnant lactating . Have Grade 3 sprain strain , bilateral sprain strain , concomitant fracture open wound site sprain strain , serious injury , determine investigator Have shoulder ( rotator cuff ) injury . Have treat sprain strain site within past 3 month . Have contusion site acute soft tissue injury intend treatment . Have active skin lesion disease intend site application study medication . Have pharmacologic treatment injury le 24 hour baseline assessment Use oral parenteral corticosteroid within 30 day injury . Have nonpharmacologic treatment injury rest , ice , compression , and/or elevation ( RICE ) within 12 hour prior baseline visit . Have history physical examination find incompatible safe participation study . Have history physical examination finding , opinion investigator , incompatible study product use obtain interpretable data . Are take medication substance contraindicate due nature study medication potential drug interaction . Are allergic sensitive soy lecithin soy lecithincontaining product . Are take probenecid similar drug may significantly affect renal function . Are take sleep medication , sedative hypnotic , anxiolytic , antidepressant medication dose stable least 2 month . Are receive physical therapy index injury Have schedule elective surgery invasive procedure period study participation . Have illness concurrent condition would , opinion investigator , make study participation unsafe would confound study result ly undergoing treatment chronic pain , severe systemic disease ) . Have receive investigational drug product participate investigational drug study within period 30 day prior receive study medication . Have active worker 's compensation claim personal injury claim regard injury index site . Are suspected investigator recent current drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Sprain</keyword>
	<keyword>Strain</keyword>
	<keyword>Pain</keyword>
	<keyword>Ankle Pain</keyword>
	<keyword>Knee Pain</keyword>
	<keyword>Wrist Pain</keyword>
	<keyword>Hand Pain</keyword>
</DOC>